Integral Diagnostics | IDX - Ebit

Aktienkurs
2.27
Täglich Wechseln
0 0%
Monatlich
-3.81%
Jährlich
0.44%
Q2 Prognose
2.20




Ebit Veränderung Datum
Alcidion AUD 2.2M 1.76M 2025-12
Ansell USD 146.5M 29.2M 2025-12
Cochlear AUD 261.1M 13.9M 2025-12
CSL USD 2.64B 116M 2025-12
Healius AUD 23.7M 26M 2024-12
Mayne Pharma AUD -16.2M 13.2M 2024-06
Monash IVF AUD 18M 6.11M 2025-12
Nanosonics AUD 9.12M 422K 2025-12
Polynovo AUD 2.06M 1.18M 2025-12
Ramsay Health Care AUD 541.1M 20.7M 2025-12
ResMed USD 497.6M 35.25M 2025-12
Sigma Healthcare AUD 809K 13.76M 2024-12
Sonic Healthcare AUD 423.94M 80.3M 2024-12
Telix Pharmaceuticals AUD 8.04M 3.21M 2025-12